Catheter Antitrust Claims Against CR Bard Nixed
A federal judge has tossed out antitrust claims against medical technology manufacturer C.R. Bard Inc., accused by hospitals of hatching a scheme that purportedly drove up prices of urological catheters....To view the full article, register now.
Already a subscriber? Click here to view full article